The size of the Europe beta-glucan market is expected to be worth USD 143.54 million in 2024 and grow at a CAGR of 6.97% from 2024 to 2029 to achieve USD 201.05 million by 2029.
Beta-glucans belong to a family of β-D-glucose polysaccharides that form basic structures in the cell walls of bacteria and fungi, as well as grains such as oats and barley. Beta-glucan is a partially water-soluble type of dietary fiber. It plays an important role in controlling cholesterol levels, controlling blood sugar, and maintaining a healthy heart. It plays an effective role in regulating high cholesterol levels and further influence the treatment of the immune system when affected by HIV / AIDS, cancer, diabetes, etc. The use of beta glucan helps to strengthen the immune system and is effective in preventing colds and coughs. Beta-glucans are available in supplement form as a form of dietary fiber that optimizes cholesterol levels and promotes heart health, and some of the common sources include wheat, bran, oats, and barley. They can also be extracted from the cell walls of yeast, algae, moss, bacteria, and fungi. Beta-glucan is available in supplement form and is used as a food additive in a variety of consumer foods, such as frozen desserts and salads. As health awareness among consumers increases and preferences for natural and unprocessed foods increase, it is expected to be a major driver of the Europe Beta-Glucan market during the forecast period.
The rise in chronic health conditions such as heart disease, cholesterol, diabetes, and obesity will attract consumer interest in consuming healthy diet foods such as Europe Beta-Glucan for years to come. In addition, as the agricultural sector in developing countries grows, market demand for Beta-Glucan is expected to continue to increase as the cultivation of soybeans and corn, the raw materials for the production of products are increases. The industry shows high growth potential, which has led major players to focus on developing high-end formulations that provide excellent health benefits to ensure cash in a rapidly developing Europe Beta-Glucan market. Increasing consumer awareness of the ability to control blood cholesterol levels and the need to maintain personal health and hygiene may drive the Europe Beta-Glucan market growth. The Europe Beta-Glucan market is driven primarily by the fact that an increasingly health conscious consumer population forms a strong segment of the consumer base. Additionally, an increase in disposable income is expected to boost the Europe Beta-Glucan market. Regular consumption of beta-glucan helps reduce your risk factors for diabetes. As stress-related disorders increase and the prevalence of lifestyle-related diseases, such as diabetes and heart dysfunction, increases, people around the region are rapidly changing their eating habits. The Europe Beta-Glucan will benefit from these advances, as beta-glucan foods are an efficient source of energy.
In addition, the overall quality is often determined by the consumer by certification related to the product. Industry consumers are highly appreciated for the source of the product. The industry is characterized by a remarkable regulatory framework with regulations related to the processing, packaging and transportation of products. The increase in retail stores, grocery stores and supermarkets offering products is expected to drive growth in the industry. The use of seaweed in the extraction process is increasing, with huge investments signaled by companies expected to drive growth in the industry during the outlook period. Increasing product innovation and growing demand for beta glucan in emerging markets will increase market demand for Beta-Glucan in the coming years. The growing demand for a wide range of accessories and other innovative products from the cosmetic industry is driving the Europe Beta-Glucan Market.
The Europe Beta-Glucan market also faces several shortcomings, with the high price of the beta glucan extraction procedure combined with minimal algae in many regions are hampering the growth of the market. The final grain-derived extract product is expected to reduce demand for the product somewhat during the forecast period. Factors such as the increased number of advertisements and the marketing of alternative products are expected to hamper the growth of the Europe Beta-Glucan. The main obstacle in the market is the discrepancy in the regulatory standards governing beta glucan. Health claims also vary by country level, preventing the use of beta glucans in foods and beverages, as well as pharmaceuticals.
The Europe Beta-Glucan market was dominated by soluble segment followed by the insoluble in terms of value in 2019. Improvements in the economic situation are expected to accelerate the growth of beta glucans as living standards rise. As a result, manufacturers can increase production.
The Europe Beta-Glucan market is segmented according to origin as yeasts, mushrooms, cereals and algae. Cereals and yeast are the main sources of beta-glucan. Beta glucans in grains like oats and barley dominated the market in 2019.
The pharmaceutical sector held the largest market share in 2019. Yeast beta-glucan is increasingly considered a nutraceutical ingredient that has a positive effect on the immune system.
The presence of several major players in Europe, along with changing consumer preferences for the consumption of functional supplements, coupled with high disposable income, will drive growth for the product over the next eight years. Many companies are focused on using innovative technologies to make products designed specifically for end-use industries that can drive growth. Germany dominated the European market for beta glucans with sales of xx million dollars in 2020. The growth of the local market is driven by advances in the personal care sector and by the approvals related to beta glucans provided to private organizations by the authorities of food safety. Other potential markets for beta glucan in Europe are Italy, the UK, Spain, France and other European regions.
Major Key Players in the Global Europe Beta-Glucan Market are Biothera Pharmaceuticals Inc, Biotec Pharmacon ASA, AIT Ingredients, Super Beta Glucan Inc, Ceapro Inc, Tate & Lyle Plc, DSM NV, Kerry Group PLC, Millipore Sigma, Kemin Industries, Cargill Inc, Garuda International Inc, and Lesaffre
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 1400
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]
Reports By Region